Hirsch EB - Search Results

1

Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommendations.

Bixby ML, Salay JM, Krueger AR, Mathers AJ, Hirsch EB. Bixby ML, et al. Among authors: hirsch eb. Microbiol Spectr. 2023 Mar 6;11(2):e0336322. doi: 10.1128/spectrum.03363-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36877020 Free PMC article.

2

Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.

Smith EC, Brigman HV, Anderson JC, Emery CL, Bias TE, Bergen PJ, Landersdorfer CB, Hirsch EB. Smith EC, et al. Among authors: hirsch eb. J Clin Microbiol. 2020 Sep 22;58(10):e01121-20. doi: 10.1128/JCM.01121-20. Print 2020 Sep 22. J Clin Microbiol. 2020. PMID: 32669380 Free PMC article.

3

Opportunities for antibiotic stewardship in emergency department or hospitalized patients with asymptomatic bacteriuria: identifying risk factors for antibiotic treatment.

Bixby ML, Raux BR, Bhalla A, McCoy C, Hirsch EB. Bixby ML, et al. Among authors: hirsch eb. Antimicrob Steward Healthc Epidemiol. 2022 Jan 31;2(1):e16. doi: 10.1017/ash.2022.4. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36310811 Free PMC article.

4

Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for Klebsiella pneumoniae.

Bixby ML, Daley EC, Collins LB, Salay JM, Bryson AL, Hirsch EB. Bixby ML, et al. Among authors: hirsch eb. Microbiol Spectr. 2024 Aug 6;12(8):e0420523. doi: 10.1128/spectrum.04205-23. Epub 2024 Jun 28. Microbiol Spectr. 2024. PMID: 38940588 Free PMC article.

5

Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales.

Zheng D, Bergen PJ, Landersdorfer CB, Hirsch EB. Zheng D, et al. Among authors: hirsch eb. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0144621. doi: 10.1128/AAC.01446-21. Epub 2021 Nov 22. Antimicrob Agents Chemother. 2022. PMID: 34807759 Free PMC article. Review.

6

Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles.

Rees CA, Nasir M, Smolinska A, Lewis AE, Kane KR, Kossmann SE, Sezer O, Zucchi PC, Doi Y, Hirsch EB, Hill JE. Rees CA, et al. Among authors: hirsch eb. Sci Rep. 2018 Sep 5;8(1):13297. doi: 10.1038/s41598-018-31543-x. Sci Rep. 2018. PMID: 30185884 Free PMC article.

7

Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists.

Wenzler E, Maximos M, Asempa TE, Biehle L, Schuetz AN, Hirsch EB. Wenzler E, et al. Among authors: hirsch eb. Pharmacotherapy. 2023 Apr;43(4):264-278. doi: 10.1002/phar.2781. Epub 2023 Mar 16. Pharmacotherapy. 2023. PMID: 36825480

8

Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: A patient-level analysis of published data.

O'Donnell JN, Rhodes NJ, Biehle LR, Esterly JS, Patel TS, McLaughlin MM, Hirsch EB. O'Donnell JN, et al. Among authors: hirsch eb. Int J Antimicrob Agents. 2020 Feb;55(2):105849. doi: 10.1016/j.ijantimicag.2019.11.006. Epub 2019 Nov 23. Int J Antimicrob Agents. 2020. PMID: 31770628

9

Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from U.S. medical centres.

Hirsch EB, Brigman HV, Zucchi PC, Chen A, Anderson JC, Eliopoulos GM, Cheung N, Gilbertsen A, Hunter RC, Emery CL, Bias TE. Hirsch EB, et al. J Glob Antimicrob Resist. 2020 Sep;22:689-694. doi: 10.1016/j.jgar.2020.04.017. Epub 2020 Apr 27. J Glob Antimicrob Resist. 2020. PMID: 32353524 Free article.

10

Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model.

Bilal H, Peleg AY, McIntosh MP, Styles IK, Hirsch EB, Landersdorfer CB, Bergen PJ. Bilal H, et al. Among authors: hirsch eb. J Antimicrob Chemother. 2018 Jun 1;73(6):1570-1578. doi: 10.1093/jac/dky045. J Antimicrob Chemother. 2018. PMID: 29506207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters